ETV6-ABL1-positive “chronic myeloid leukemia”: clinical and molecular response to tyrosine kinase inhibition

Por Perna, Fabiana, Abdel-Wahab, Omar, Levine, Ross L., Jhanwar, Suresh C., Imada, Kazunori, Nimer, Stephen D.
Publicado em 2011

Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF

Por Yano, Hiroki, Ishida, Takashi, Imada, Kazunori, Sakai, Tomomi, Ishii, Toshihiko, Inagaki, Atsushi, Iida, Shinsuke, Uchiyama, Takashi, Ueda, Ryuzo
Publicado em 2008

Palmitic Acid Induces Osteoblastic Differentiation in Vascular Smooth Muscle Cells through ACSL3 and NF-κB, Novel Targets of Eicosapentaenoic Acid

Por Kageyama, Aiko, Matsui, Hiroki, Ohta, Masahiko, Sambuichi, Keisuke, Kawano, Hiroyuki, Notsu, Tatsuto, Imada, Kazunori, Yokoyama, Tomoyuki, Kurabayashi, Masahiko
Publicado em 2013

APOBEC3G targets human T-cell leukemia virus type 1

Por Sasada, Amane, Takaori-Kondo, Akifumi, Shirakawa, Kotaro, Kobayashi, Masayuki, Abudu, Aierkin, Hishizawa, Masakatsu, Imada, Kazunori, Tanaka, Yuetsu, Uchiyama, Takashi
Publicado em 2005

Stat5b Is Essential for Natural Killer Cell–mediated Proliferation and Cytolytic Activity

Por Imada, Kazunori, Bloom, Eda T., Nakajima, Hiroshi, Horvath-Arcidiacono, Judith A., Udy, Garry B., Davey, Helen W., Leonard, Warren J.
Publicado em 1998

Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study

Por Ishida, Takashi, Jo, Tatsuro, Takemoto, Shigeki, Suzushima, Hitoshi, Uozumi, Kimiharu, Yamamoto, Kazuhito, Uike, Naokuni, Saburi, Yoshio, Nosaka, Kisato, Utsunomiya, Atae, Tobinai, Kensei, Fujiwara, Hiroshi, Ishitsuka, Kenji, Yoshida, Shinichiro, Taira, Naoya, Moriuchi, Yukiyoshi, Imada, Kazunori, Miyamoto, Toshihiro, Akinaga, Shiro, Tomonaga, Masao, Ueda, Ryuzo
Publicado no Br J Haematol (2015)